FNDC5 and Parkinson disease: The ultimate question regarding irisin in PD is not whether irisin is “important” or “interesting” (clearly, the evidence suggests mechanistic plausibility), but rather whether irisin is therapeutically actionable, whether enhancing irisin production or signaling becomes disease-modifying in human PD.